Shopping Cart
- Remove All
Your shopping cart is currently empty
Ozuriftamab (BA302) is a human immunoglobulin IgG1 kappa monoclonal antibody specifically designed to target the receptor tyrosine kinase-like orphan receptor 2 (ROR2), and this antibody serves as the foundational targeting moiety for the synthesis of antibody-drug conjugates (ADCs), such as Ozuriftamab vedotin.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $185 | In Stock | |
| 5 mg | $465 | In Stock | |
| 10 mg | $745 | In Stock | |
| 25 mg | $1,160 | In Stock | |
| 50 mg | $1,560 | In Stock |
| Description | Ozuriftamab (BA302) is a human immunoglobulin IgG1 kappa monoclonal antibody specifically designed to target the receptor tyrosine kinase-like orphan receptor 2 (ROR2), and this antibody serves as the foundational targeting moiety for the synthesis of antibody-drug conjugates (ADCs), such as Ozuriftamab vedotin. |
| Synonyms | BA302, BA 302 |
| Cas No. | 2460399-44-2 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.